Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Real-World Study Investigating the Effects of Dulaglutide and Insulin Glargine on Renal Function in Patients with Type 2 Diabetes (T2D)

Trial Profile

A Real-World Study Investigating the Effects of Dulaglutide and Insulin Glargine on Renal Function in Patients with Type 2 Diabetes (T2D)

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2018

At a glance

  • Drugs Dulaglutide (Primary) ; Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 06 Aug 2018 Results published in the Clinical Therapeutics
    • 19 Jul 2018 New trial record
    • 26 Jun 2018 Results presented at the 78th Annual Scientific Sessions of the American Diabetes Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top